Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Schenkein

Internal Medicine Boston, MA Medical Doctor

NPI 1144330176 CMS profile 1050699

800 Washington St, Tufts Medical Center, Box 836, Boston, MA 02111

Open in the dashboard

General payments

$4,964,417

186 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$1,186,743

3 holdings reported · through program year 2025

Through program year 2025, David Schenkein of Boston, MA is reported in the CMS Open Payments database as having received $4,964,417 across 186 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $1,186,743 across 3 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Internal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $920,430 62
2024 General $829,812 47
2023 General $1,627,753 25
2022 General $574,324 16
2021 General $261,458 15
2020 General $749,904 17
2019 General $736 4
2025 Ownership $197,173 1
2024 Ownership $395,464 1
2023 Ownership $594,106 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Schenkein
  • Internal Medicine median
  • Middle half of Internal Medicine
  • National median

In program year 2025, general payments to David Schenkein were reported at $920,430. Among 52,115 Internal Medicine profiles paid that year, the median was $156 and the middle half received between $47 and $551.

Show as a table
Year David Schenkein Internal Medicine median Middle half National median
2019 $736 $159 $48–$570 $163
2020 $749,904 $119 $33–$402 $114
2021 $261,458 $135 $37–$521 $132
2022 $574,324 $141 $42–$496 $149
2023 $1,627,753 $149 $45–$519 $160
2024 $829,812 $154 $47–$537 $164
2025 $920,430 $156 $47–$551 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Regeneron Pharmaceuticals, Inc. $2,591,221 129 payments
  2. Agios Pharmaceuticals, Inc. $1,426,820 27 payments
  3. BeiGene, Ltd. $814,668 20 payments
  4. BeOne Medicines Ltd. $122,201 2 payments
  5. BeOne Medicines USA, Inc. $8,750 3 payments
  6. Genentech, Inc. $596 2 payments
  7. Bristol-Myers Squibb Company $104 1 payment
  8. GlaxoSmithKline, LLC. $35 1 payment
  9. Cortex, Inc. $21 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $3,747,188 81 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,162,828 10 payments
  3. Travel and Lodging $47,968 24 payments
  4. Food and Beverage $6,433 71 payments
Products named General payments · program years 2019–2025
  1. PYRUKYND $141 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

186 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Internal Medicine in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record